25 news items
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
BMY
23 May 24
transfusion independence and overall survival in lower-risk myelodysplastic syndromes
Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
BMY
21 May 24
independently, enjoys yoga and dance, and is doing really well. We want to get rid of the negative images many of us have of schizophrenia and raise
Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
BMY
15 May 24
or complete response per Lugano criteria as assessed by an Independent Review Committee (IRC). The complete response (CR) rate was 73.4% (95% CI: 63.3
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
BMY
10 May 24
of the trial is progression-free survival (PFS) by RECIST 1.1 per blinded independent central review (BICR) for Arm A vs. Arm C. Secondary endpoints include
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
BMY
26 Apr 24
of overall survival (OS) and progression-free survival (PFS) as assessed by Blinded Independent Central Review (BICR). With a median follow up
bd7yz1bwl3qtd fjfrqwlo17q1c5cw1vl
BMY
25 Apr 24
Independent
ooh33msg640c4ztoy b0lwd
ABBV
ATNM
AZN
19 Apr 24
is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com
7bcmba9pc 73cf4
ATNM
AZN
BMY
18 Apr 24
. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker-dealer, broker, investment advisor
tb5y5l9wbxf64wbcrvgzt9t26st60eg1wa51z7
ATNM
AZN
BMY
17 Apr 24
broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker-dealer, broker, investment
ld06o4mgpz 25t2qtp6wyxr38e1qoas8a7q0ldfbek808s6nd49bh
BMY
6 Apr 24
, people living with schizophrenia often struggle to maintain employment, live independently, and manage relationships. While current treatments can
xm2ju4bn1k0y8a19gbyz4ynzqit0whlcjq6rs8aeuxd3l7kd41li
BMY
IRON
VERV
4 Apr 24
demonstrated superior efficacy compared to epoetin alfa in the study's primary endpoint of concurrent red blood cell transfusion independence and hemoglobin
h2wcztkgqfzf6xc5kvp9z410iq7wa8laql5n tw53o5eo0
BMY
3 Apr 24
the percentage of patients achieving transfusion independence and hemoglobin increase, along with increased durability compared to epoetin alfa
fcp31fhjnofnpped 5i0clcj
BMY
2 Apr 24
study, in which Reblozyl nearly doubled the percentage of patients achieving transfusion independence
ww009rzk kusbneda5glhf8watvtgaj05035b0bkx3uk7xsred7bi9g89k
ARGX
ATNM
AZN
22 Mar 24
zero shares of ATNM. InvestorBrandMedia.com is neither an investment advisor nor a registered broker. No current owner, employee, or independent
la6oepyc1rpm wi6vzmlk8vpftn5v
ABBV
ANIX
BIIB
20 Mar 24
. InvestorBrandMedia.com is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com